Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).
Clinical trial NCT03562819 · COMPLETED
Trial details
- NCT number
- NCT03562819
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-16
- Primary completion
- 2019-06-07
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.